D
국전
307750KOSDAQ의약품 제조업34.5 / 100
Reference Date: 2026-06-10
Financial Score9.0 / 40
News Sentiment12.5 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, Operating Profit is on a declining trend. Plunged 35.7% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Kukjeon Pharm operates two main business segments: the pharmaceutical division, focusing on the synthesis and distribution of active pharmaceutical ingredients (APIs), and the materials division, developing high-performance specialty materials for advanced industries such as OLEDs, semiconductors, and AI. The company is strengthening its competitiveness through new drug development and global market expansion.
Number of Employees
172people
Average Salary
68.9M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 11.934.0Point
PBR
1.36Industry Average 0.891.0Point
1.5x industry avg (risky)
ROE
-4.99Industry Average 4.010.0Point
Well below industry avg
Debt Ratio
18.00Industry Average 12.432.0Point
Higher than industry avg (caution)
Trend 2023~20252.0 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲3.9% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼446.9% (2-year basis)
ROE Trend
1.0 / 4
Avg ROE 0.2% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 2,410Won52-week high 5,54052-week low 2,410
1-month return0.0Point
1m -35.73% (strong drop)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
5 totalPositive 0Neutral 5Negative 0
- Neutral주식등의대량보유상황보고서(일반)2026-06-08
- Neutral주식등의대량보유상황보고서(일반)2026-05-28
- Neutral신주인수권행사가액의조정2026-05-27
- Neutral분기보고서 (2026.03)2026-05-15
- Neutral주식등의대량보유상황보고서(일반)2026-05-12